What is Color?
Founded in 2015 and headquartered in Burlingame, California, Color offers low-cost, physician-ordered genetic testing. Their service includes comprehensive support for physicians and genetic counseling as an integral part of every purchase. This approach aims to make advanced genetic insights more accessible and actionable for healthcare providers and patients alike, positioning Color as a key player in the personalized medicine landscape.
How much funding has Color raised?
Color has raised a total of $482M across 6 funding rounds:
Series A
$15M
Series B
$45M
Series C
$80M
Other Financing Round
$75M
Series D
$167M
Series E
$100M
Series A (2015): $15M with participation from Khosla Ventures and Formation8
Series B (2016): $45M led by Emerson Collective, General Catalyst, 8VC, and Khosla Ventures
Series C (2017): $80M supported by CRV, Lefrak Organization, Emerson Collective, LionTree, and General Catalyst
Other Financing Round (2020): $75M featuring Viking Global Investors and T. Rowe Funds
Series D (2021): $167M backed by General Catalyst Partners, Viking Global Investors, and T. Rowe Price
Series E (2021): $100M with participation from Kindred Ventures, T. Rowe Price, General Catalyst, Emerson Collective, and Viking Global Investors
Key Investors in Color
CRV
CRV is a venture capital firm that invests in early-stage tech startups, known for backing companies like Airtable and DoorDash. They provide long-term partnership and capital to help founders build great companies from inception through IPO and beyond.
Emerson Collective
Emerson Collective invests in entrepreneurs and innovators focused on purpose-driven solutions, aiming to expand opportunity and foster human flourishing. They address complex challenges in education, economic mobility, immigration, and the environment.
General Catalyst
General Catalyst is a venture capital firm that supports transformational business opportunities across various sectors and stages, partnering with entrepreneurs to accelerate growth and build enduring enterprises through deep sector expertise and operational support.
What's next for Color?
The recent major strategic investment in Color signals a strong confidence from its backers in the company's future trajectory. With substantial capital raised over its history, Color is well-positioned to further innovate its genetic testing platform, expand its service offerings, and potentially scale its operations to reach a broader market. The company's focus on integrating physician support and genetic counseling suggests a strategy geared towards clinical adoption and long-term impact in healthcare.
See full Color company page
